Early neurologic abnormalities associated with human T-cell lymphotropic virus type 1 infection in a cohort of Peruvian children
- PMID: 19628219
- PMCID: PMC2764792
- DOI: 10.1016/j.jpeds.2009.05.027
Early neurologic abnormalities associated with human T-cell lymphotropic virus type 1 infection in a cohort of Peruvian children
Abstract
Objective: Because human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) may occur in some children infected with HTLV-1, we sought to determine the prevalence of neurologic abnormalities and any associations of neurologic abnormalities with infective dermatitis in these children.
Study design: We enrolled 58 children infected with HTLV-1 and 42 uninfected children (ages 3 to 17) of mothers infected with HTLV-1 in a family study in Lima, Peru. We obtained medical and developmental histories, surveyed current neurologic symptoms, and conducted a standardized neurologic examination without prior knowledge of HTLV-1 status.
Results: HTLV-1 infection was associated with reported symptoms of lower extremity weakness/fatigue (odds ratio [OR], 6.1; confidence interval [CI], 0.7 to 281), lumbar pain (OR, 1.7; 95% CI, 0.4 to 8), and paresthesia/dysesthesia (OR, 2.6; CI, 0.6 to 15.8). HTLV-1 infection was associated with lower-extremity hyperreflexia (OR, 3.1; CI, 0.8 to 14.2), ankle clonus (OR, 5.0; CI, 1.0 to 48.3), and extensor plantar reflex (OR undefined; P = .2). Among children infected with HTLV-1, a history of infective dermatitis was associated with weakness (OR, 2.7; CI, 0.3 to 33), lumbar pain (OR, 1.3; CI, 0.2 to 8), paresthesia/dysesthesia (OR, 2.9; CI, 0.5 to 20), and urinary disturbances (OR, 5.7; CI, 0.5 to 290).
Conclusions: Abnormal neurologic findings were common in Peruvian children infected with HTLV-1, and several findings were co-prevalent with infective dermatitis. Pediatricians should monitor children infected with HTLV-1 for neurologic abnormalities.
Similar articles
-
Urinary symptoms associated with human T-cell lymphotropic virus type I infection: evidence of urinary manifestations in large group of HTLV-I carriers.Urology. 2007 May;69(5):813-8. doi: 10.1016/j.urology.2007.01.052. Urology. 2007. PMID: 17482910
-
Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy.Neurology. 2009 Sep 8;73(10):781-9. doi: 10.1212/WNL.0b013e3181b6bba9. Neurology. 2009. PMID: 19738173 Free PMC article.
-
Human T-cell lymphotropic virus type I (HTLV-I)-related clinical and laboratory findings for HTLV-I-infected blood donors.J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):328-34. doi: 10.1097/00126334-200303010-00013. J Acquir Immune Defic Syndr. 2003. PMID: 12626894
-
Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.Rev Neurol (Paris). 2012 Mar;168(3):257-69. doi: 10.1016/j.neurol.2011.12.006. Epub 2012 Mar 7. Rev Neurol (Paris). 2012. PMID: 22405461 Review.
-
Infective dermatitis associated with human T-cell lymphotropic virus type-1, an underdiagnosed disease.Int J Infect Dis. 2024 Aug;145:107058. doi: 10.1016/j.ijid.2024.107058. Epub 2024 Apr 30. Int J Infect Dis. 2024. PMID: 38697604 Review.
Cited by
-
Emerging and re-emerging infectious diseases in Iran.Iran J Microbiol. 2017 Jun;9(3):122-142. Iran J Microbiol. 2017. PMID: 29225752 Free PMC article. Review.
-
Implications of human T-lymphotropic virus in pregnancy: A case report and a review of the diagnostic criteria and management proposal.Exp Ther Med. 2021 Jan;21(1):82. doi: 10.3892/etm.2020.9514. Epub 2020 Nov 26. Exp Ther Med. 2021. PMID: 33363593 Free PMC article.
-
HTLV-1-associated infective dermatitis and probable HTLV-1- associated myelopathy in an adolescent female.An Bras Dermatol. 2015 May-Jun;90(3 Suppl 1):55-8. doi: 10.1590/abd1806-4841.20153462. An Bras Dermatol. 2015. PMID: 26312674 Free PMC article.
-
Mother-to-Child Transmission of Human T-Cell Leukemia Virus Type 1: Mechanisms and Nutritional Strategies for Prevention.Cancers (Basel). 2021 Aug 14;13(16):4100. doi: 10.3390/cancers13164100. Cancers (Basel). 2021. PMID: 34439253 Free PMC article. Review.
-
Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathy.PLoS Negl Trop Dis. 2012;6(7):e1729. doi: 10.1371/journal.pntd.0001729. Epub 2012 Jul 24. PLoS Negl Trop Dis. 2012. PMID: 22848768 Free PMC article.
References
-
- Edlich RF, Arnette JA, Williams FM. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I) J Emerg Med. 2000;18:109–119. - PubMed
-
- Gotuzzo E, Arango C, de Queiroz-Campos A, Istúriz RE. Human T-cell lymphotropic virus-I in Latin America. Infect Dis Clin North Am. 2000;14:211–239. x–xi. - PubMed
-
- Verdonck K, González E, Van Dooren S, Vandamme A, Vanham G, Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. The Lancet Infectious Diseases. 2007;7:266–281. - PubMed
-
- Robert-Guroff M, Weiss SH, Giron JA, Jennings AM, Ginzburg HM, Margolis IB, et al. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA. 1986;255:3133–3137. - PubMed
-
- Kelen GD, DiGiovanna TA, Lofy L, Junkins E, Stein A, Sivertson KT, et al. Human T-lymphotropic virus (HTLV I-II) infection among patients in an inner-city emergency department. Ann Intern Med. 1990;113:368–72. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous